New Directions in Melanoma Research

VIDEO | 08:00

Memorial Sloan Kettering medical oncologist Paul Chapman that new information about the biological processes that cause melanoma to spread is being used to develop more effective therapies for the disease. BRAF inhibitors, a type of immunotherapy, are more effective than standard chemotherapy, but many tumors become resistant to these medications. Dr. Chapman and other melanoma researchers are working to develop new drugs that prevent tumors from developing resistance, and to determine which tumors will be most likely to benefit from immunotherapy.